Remgro (REM) CMD 2025 summary
Event summary combining transcript, slides, and related documents.
CMD 2025 summary
20 Dec, 2025Strategic Priorities and Portfolio Evolution
Focused on active performance optimization, strategic capital allocation, and sustainability, reducing priorities from five to three for sharper execution.
Portfolio shifted from 23% to 63% private assets and from 5% to 38% global partner ownership between 2019 and 2024, enhancing scarcity and value creation.
Over five years, allocated ZAR 80 billion in capital, with 50% returned to shareholders, 20% for investments, and 20% for de-gearing, resulting in a debt-free center.
Emphasized patient capital, active partnerships, and a long-term, Africa-centric investment approach, with a strong focus on South African prosperity.
Ongoing simplification of the portfolio, with a commitment to exit tail investments and focus on areas where meaningful influence and value can be added.
Financial Performance and Capital Allocation
Achieved a five-year IRR to shareholders (including unbundled shares) of 20.5% as of March 2025, outperforming key indices, but acknowledged underperformance relative to peers.
Maintained steady dividend growth since 2021, aiming to increase dividend yield as cash generation at the center improves.
Portfolio discount to intrinsic NAV remains high at 44.7% (1-year) after unbundling and restructuring actions, with 20% of the portfolio (notably HEINEKEN, Hirslanden, and CIVH) not currently contributing to earnings.
Positive cash generation has been used to deleverage and strengthen the balance sheet, with significant investments and debt repayments since 2019.
Capital allocation priorities: support portfolio resilience, pay cash dividends, follow-on strategic investments, share repurchases (attractive at high discount), new investments, and debt repayment (currently no debt at center).
Business Development and Growth Opportunities
Organic growth prioritized over inorganic, with a strong preference for investing in familiar markets and leveraging partnerships for risk mitigation in new geographies.
Identified a market gap for mid-sized investments (ZAR 5–15 billion), as private equity and public markets have limited activity in this range.
Mediclinic and CIVH highlighted as key growth drivers, with Mediclinic focusing on operational efficiency, digital transformation, and expanding specialized care, while CIVH targets closing the digital divide and expanding fibre connectivity across South Africa.
CIVH’s fibre network now passes 2 million homes, with 860,000 active subscribers and strong growth in lower LSM areas; business model emphasizes sweating existing assets and driving penetration to improve returns.
ESG and impact investing are integral, with ongoing groupwide initiatives in climate, diversity, governance, and social impact, especially in education and community connectivity.
Latest events from Remgro
- HEPS expected to rise 36%–41% year-over-year for the six months ended 31 December 2025.REM
H1 2026 TU13 Mar 2026 - Headline earnings down 20%, dividend up 10%, with strong OUTsurance and RCL Foods results.REM
H2 202420 Jan 2026 - All resolutions passed as shareholders engaged on strategy, incentives, and global risks.REM
AGM 202412 Jan 2026 - Headline earnings up 38.7%, INAV per share up 10.3%, and dividend up 20%.REM
H1 20251 Dec 2025 - Maziv's ZAR 38.75bn deal advances with regulatory support, CapEx, and BEE commitments.REM
Investor Update13 Nov 2025 - Headline earnings up 38.6%, ordinary dividend up 30.3%, and balance sheet fully de-geared.REM
H2 202516 Oct 2025